Gniewkiewicz, M.; Czerwinska, K.; Zielniok, K.; Durlik, M.
Impact of Resolved Preformed, Persistent Preformed, and De Novo Anti-HLA Donor-Specific Antibodies in Kidney Transplant Recipients on Long-Term Renal Graft Outcomes. J. Clin. Med. 2023, 12, 3361.
https://doi.org/10.3390/jcm12103361
AMA Style
Gniewkiewicz M, Czerwinska K, Zielniok K, Durlik M.
Impact of Resolved Preformed, Persistent Preformed, and De Novo Anti-HLA Donor-Specific Antibodies in Kidney Transplant Recipients on Long-Term Renal Graft Outcomes. Journal of Clinical Medicine. 2023; 12(10):3361.
https://doi.org/10.3390/jcm12103361
Chicago/Turabian Style
Gniewkiewicz, Michal, Katarzyna Czerwinska, Katarzyna Zielniok, and Magdalena Durlik.
2023. "Impact of Resolved Preformed, Persistent Preformed, and De Novo Anti-HLA Donor-Specific Antibodies in Kidney Transplant Recipients on Long-Term Renal Graft Outcomes" Journal of Clinical Medicine 12, no. 10: 3361.
https://doi.org/10.3390/jcm12103361
APA Style
Gniewkiewicz, M., Czerwinska, K., Zielniok, K., & Durlik, M.
(2023). Impact of Resolved Preformed, Persistent Preformed, and De Novo Anti-HLA Donor-Specific Antibodies in Kidney Transplant Recipients on Long-Term Renal Graft Outcomes. Journal of Clinical Medicine, 12(10), 3361.
https://doi.org/10.3390/jcm12103361